AVERY BIO CORPORATION
Biotech · Private
Semiconductor chip device for massively parallel DNA gene synthesis and assembly using electronic control
- Grants
- $1.5M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 8
- 0 granted · 8 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Electronically Addressable DNA Assembly | $275,766 | |
| Federal grant | Department of Health and Human Services · Phase I · Long DNA Assembly on Electronic Nanochannel Chip Devices | $295,923 | |
| Federal grant | Department of Health and Human Services · Phase II · Integrated Circuit Electrical DNA Assembly | $894,545 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1334 | JT PHARMACEUTICALS, INC. | — | — |
| 1335 | YUMA THERAPEUTICS CORPORATION | — | — |
| 1336 | MINUTIA INC | — | — |
| 1337 | AVERY BIO CORPORATION | — | — |
| 1338 | SANERON CCEL THERAPEUTICS, INC. | — | — |
| 1339 | Cell-Free Bioinnovations Inc. | — | — |
| 1340 | RES GROUP, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Electronic Devices And Methods For Scalable Cellular Engineering And Screeningapplication
- Iterative Artificial Intelligence Methods And Systems For Design Optimization In Synthetic Biologyapplication
- Nanochannel Long Dna Assembly And Scalable End-to-end Automationapplication
- Electronic Assembly Of Long Dna Moleculesapplication
- Semiconductor Chip Devices And Methods For Polynucleotide Synthesisapplication
- Nanochannel Long Dna Assembly And Scalable End-to-end Automationapplication
- Nanochannel Long Dna Assembly And Scalable End-to-end Automationapplication
- Iterative Artificial Intelligence Methods And Systems For Design Optimization In Synthetic Biologyapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.